Showing 601 - 610 of 1027 for "Healthcare" with applied filters
Banking, Capital markets : Debt, Capital markets : Equity, Capital markets : Structured finance and securitisation, Financial and corporate, M&A, Project development, Project finance, Restructuring and insolvency
Banking, Capital markets : Debt, Capital markets : Equity, Financial and corporate, Investment funds, M&A, Project development, Restructuring and insolvency
Asset finance, Banking, Capital markets : Debt, Capital markets : Equity, Capital markets : Structured finance and securitisation, Financial and corporate, Financial services regulatory, Investment funds, M&A, Project development, Project finance, Restructuring and insolvency
Asset finance, Banking, Capital markets : Debt, Capital markets : Equity, Capital markets : Structured finance and securitisation, Financial and corporate, Financial services regulatory, Investment funds, M&A, Project development, Project finance, Restructuring and insolvency
Banking, Capital markets : Debt, Capital markets : Equity, Capital markets : Structured finance and securitisation, Financial and corporate, M&A, Private equity, Project development, Project finance
Capital markets : Debt, Capital markets : Equity, Capital markets : Structured finance and securitisation, Financial and corporate, Financial services regulatory, M&A, Project development, Restructuring and insolvency
Banking, Capital markets : Debt, Capital markets : Equity, Financial and corporate, Investment funds, M&A, Project development, Restructuring and insolvency
20 October 2016 by
Jack McDouall of Allegis B-N in Beijing considers the prospects for in-house lawyers in China’s maturing healthcare industry
11 March 2024 by
Zepos & Yannopoulos acted, in cooperation with Milbank LLP, for the shareholders of BETA CAE Systems International AG (“BETA CAE”), a leading provider of multi-domain engineering simulation solutions, on the sale of BETA CAE to Cadence Design Systems, Inc (“Cadence”), a California-based leading EDA and Intelligent System Design provider.
17 January 2024 by
Rahul Gossain has joined JSA as Chief Strategy & Brand Officer effective from 17 January 2024. With over two decades of experience, Rahul is renowned for his adept handling of international stakeholder engagement and strategic brand management. Rahul has expertise in professional services marketing across the legal, consulting and healthcare domains, has also worked extensively in corporate responsibility space.